| Financial Year |
March 31 2023 |
| Monetary Funds |
1,665,063,300.19 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
718,839,610.18 |
| Advances to Suppliers |
114,081,309.45 |
| Other Receivables |
106,812,402.25 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
917,367,726.05 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
102,081,140.29 |
| Total Current Assets |
4,066,972,848.01 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
17,914,800.00 |
| Long-term Equity Investment |
199,709,227.08 |
| Investment Properties |
-- |
| Fixed Assetes |
4,903,287,419.51 |
| Under-construction Projects |
447,184,170.55 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,101,841,782.97 |
| R&D expenses |
92,607,575.36 |
| Goodwill |
3,721,828,055.70 |
| Long-Term Deferred and Prepaid Expenses |
73,645,643.11 |
| Deferred Income Tax Assets |
45,290,952.00 |
| Other Non-Current Assets |
335,323,130.18 |
| Sub-Total of Non-Current Assets |
11,421,837,070.90 |
| Total Assets |
15,488,809,918.91 |
| Short-Term Loans |
159,986,237.08 |
| Trading Financial liabilities |
48,431.10 |
| Notes Payable |
50,000,000.00 |
| Accounts Payable |
257,499,450.55 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
114,577,307.96 |
| Taxes Payable |
44,646,242.50 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
1,236,611,815.55 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
944,430,485.59 |
| Other Current Liabilities |
3,230,743.21 |
| Sub-Total of Current Liabilities |
2,880,980,391.82 |
| Long-term Loans |
544,499,093.66 |
| Bonds Payable |
1,451,992,096.46 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
9,959,581.50 |
| Deferred Income Tax Liabilities |
89,431,337.03 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
2,188,483,384.86 |
| Total Liabilities |
5,069,463,776.68 |
| Paid-In Capital(Or Share Stock) |
1,007,098,279.00 |
| Capital Surplus |
5,807,430,417.67 |
| Surplus Reserve |
233,813,373.53 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
3,012,838,562.05 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
10,419,346,142.23 |
| Owner's Equity（Stockholder's Equity） |
10,419,346,142.23 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
15,488,809,918.91 |
